Network-based analyses suggest that combined targeting of core nodes, such as C-Myc/AKT or EMT-associated signaling axes, holds promise for overcoming the limitations of single Let-7 analogs, thereby providing a theoretical foundation for developing multi-target combinatorial therapies in GC. This evidence concerns the gene MYC and gastric cancer.